[1] Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013[J]. Cancer Lett, 2017,401:63-71. [2] Díaz P, Valenzuela Valderrama M, Bravo J, et al. Helicobacter pylori and gastric cancer:adaptive cellular mechanisms involved in disease progression[J]. Front Microbiol, 2018, 9:5. [3] Compare D, Rocco A, Nardone G. Risk factorsingastric cancer[J]. Eur Rev Med Pharmacol Sci, 2010, 14(4):302-308. [4] Polk DB, Peek RM Jr. Helicobacter pylori:gastric cancer and beyond[J]. Nat Rev Cancer, 2010,10(6):403-414. [5] Huang Y, Wang QL, Cheng DD, et al. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori[J]. Front Cell Infect Microbiol, 2016, 6:159. [6] Xiang W, Shi JF, Li P, et al. Estimation of cancer cases and deaths attributable to infection in China[J]. Cancer Causes Control, 2011, 22(8):1153-1161. [7] Mayerle J, den Hoed CM, Schurmann C, et al. Identification of genetic loci associated with Helicobacter pylori serologic status[J]. JAMA, 2013, 309(18):1912-1920. [8] Zheng Z, Jia Y, Hou L, et al. Genetic variation in α4GnT in relation to Helicobacter pylori serology and gastric cancer risk[J]. Helicobacter, 2009, 14(5):120-125. [9] Yim DH, Zhang YW, Eom SY, et al. ITGA1 polymorphisms and haplotypes are associated with gastric cancer risk in a Korean population[J]. World J Gastroenterol, 2013, 19(35):5870-5876. [10] Fukuda K, Saikawa Y, Yagi H, et al. Role of integrin α1 subunits in gastric cancerpatients with peritoneal dissemination[J]. Mol Med Rep, 2012, 5(2):336-340. [11] Kosaka N. Decoding the secret of cancer by means of extracellular vesicles[J]. J Clin Med, 2016, 5(2):pii:E22. [12] Zhou CJ, Zhang LW, Gao F, et al. Common genetic variations in the MUC5AC gene are not related to helicobacter pylori serologic status[J]. Asian Pac J Cancer Prev, 2014, 15(24):10719-10722. [13] 高芳, 秦金东, 李晶晶, 等. 包头地区汉族人群COX-2基因多态性与幽门螺杆菌感染的关系[J]. 中国卫生检验杂志, 2015, 25(2):220-222. [14] Oluwasola AO.Genetic determinants and clinico-pathological outcomes of helicobacter pylori infection[J]. Ann Ib Postgrad Med, 2014, 12(1):22-30. [15] Dadashzadeh K, Peppelenbosch MP, Adamu AI. Helicobacter pylori pathogenicity factors related to gastric cancer[J]. Can J Gastroenterol Hepatol, 2017, 2017:7942489. [16] Wu XW, Ji HZ, Yang MF, et al. Helicobacter pylori infection and inflammatory bowel disease in Asians:a meta-analysis[J]. World J Gastroenterol, 2015, 21(15):4750-4756. [17] NiccoliAsabella A, Di Palo A, Altini C, et al. Multimodality imaging in tumor angiogenesis:present status and perspectives[J]. Int J Mol Sci, 2017, 18(9). pii:E1864. [18] Nieberler M, Reuning U, Reichart F, et al. Exploring the role of RGD-recognizing integrins in cancer[J]. Cancers, 2017, 9(12):116. [19] Backert S, Tegtmeyer N. Type IV secretion and signal transduction of Helicobacter pylori cagA through interactions with host cell receptors[J]. Toxins, 2017, 9(4):115. [20] Servetas SL, Bridge DR, Merrell DS. Molecular mechanisms of gastric cancer initiation and progression by Helicobacter pylori[J]. Curr Opin Infect Dis, 2016, 29(3):304-310. [21] Fukuda K, Saikawa Y, Yagi H, et al. Role of integrin α1 subunits in gastric cancer patients with peritoneal dissemination[J]. Mol Med Rep, 2012, 5(2):336-340. [22] Yim DH, Zhang YW, Eom SY, et al. ITGA1 polymorphisms and haplotypes are associated with gastric cancer risk in a Korean population[J]. World J Gastroenterol, 2013, 19(35):5870-5876. |